project id: TCGA-PAAD; case submitter id: TCGA-IB-A5SO; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.99; rna integrity number: 7.6; age at index: 71; days to birth: -26129; days to death: 365; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1941; age at diagnosis: 26129; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 329.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 252; days to sample procurement: 0; initial weight: 240.0; portion submitter id: TCGA-IB-A5SO-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 3.0; percent necrosis: 2.0; percent neutrophil infiltration: 2.0; percent normal cells: 8.0; percent stromal cells: 65.0; percent tumor cells: 25.0; percent tumor nuclei: 50.0;